The next phase of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), ADNI4, is now recruiting participants with or without memory issues to help us continue investigating essential questions concerning the early detection of mild cognitive impairment and Alzheimer’s disease.
Nearly two decades of research have led to better methods for early detection of mild cognitive impairment and Alzheimer’s disease – making ADNI one of the most important research studies in the field. ADNI4 aims to discover, standardize, and validate measures like blood tests and brain scans to improve our understanding of the research process and inform clinical trials in the field. It will focus more on engaging participants from demographically diverse and underrepresented groups to more closely reflect the diversity of our country and those affected by Alzheimer’s disease. ADNI4 also boasts a smaller time commitment for participants than previous ADNI studies, maximizing what can be completed remotely.
Enroll Here